Developer docs
API playgroundTry for free, no card

Search company profiles

Relife

Full company profile

uuid002q7rg

Namestring
Relife
Legal namestring
Relife
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Relife is a B2B medical aesthetics company that operates as a brand within the Menarini pharmaceutical group, with its corporate seat at Menarini France in Rungis, France. The company sells a multi-modality portfolio of medical aesthetic products under the Definisse™ brand to licensed healthcare professionals and aesthetic clinics — principally dermatologists, plastic surgeons, and aesthetic practitioners — across France, Italy, Germany, Austria, Thailand, Ireland, the United Kingdom, and Benelux. Its core product families include Definisse™ Threads (tissue support threads for lifting procedures, including Revitalise and 3D Lift variants), Definisse™ Fillers (dermal fillers for volume restoration and wrinkle correction), Definisse™ Rinnova Peel (chemical peels for skin resurfacing), Definisse™ Hydrobooster (injectable hydration), Definisse™ [KP¹]® Bio-Peptide Collagen Modulator (a bio-peptide-based collagen modulator), and the Pigment Solution™ Program for hyperpigmentation. Relife also operates the RELIFE Academy, a training platform for clinicians performing aesthetic procedures.

The company operates an enterprise field sales model, distributing products directly to healthcare professionals through the Menarini regional offices in each market. It runs eight localized websites and a dedicated academy site to support clinician education and brand engagement. Revenue is generated through one-time product sales of regulated medical devices and consumables via prescription/clinical channels; pricing is not publicly disclosed. Relife leverages the parent group's clinical, regulatory, manufacturing, and distribution infrastructure, but does not publish standalone financials, headcount, management roster, funding history, or independent revenue figures. As a brand subsidiary within a larger pharmaceutical company, Relife's strategic positioning is shaped by Menarini's broader medical aesthetics and pharmaceutical operations rather than by independent capital allocation.

Short descriptiontext

Relife is a B2B medical aesthetics brand and Menarini Group subsidiary that sells the Definisse™ portfolio of threads, fillers, peels, hydration injectables, and bio-peptide collagen modulators to licensed aesthetic practitioners across eight European and Asian markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersRungis, France
HQ citystring
Rungis
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical aesthetics products, dermal fillers, tissue support threads, chemical peels, bio-peptide treatments
Industry3 codes
PRIMARYHLAKACAE
Cosmetic Dermatology (Aesthetic Injectables)
SECONDARYCRABALAF
Professional Skincare & Facial Treatments
Consumer Products & Retail/Beauty & Personal Care/Professional Salon & Spa Products
SECONDARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Perfumes, Cosmetics & Other Toilet Preparations2844
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Aesthetics
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Aesthetic Products
TypeOne Time License
Description

Relife generates revenue through the sale of medical aesthetic products including tissue support threads, dermal fillers, chemical peels, and bio-peptide treatments to healthcare professionals and aesthetic clinics.

relife-aesthetics.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Marketing or Sales, Personnel, Operations, Technology or R&D
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1Definisse™ Threads
Description

Fils de soutien tissulaire (tissue support threads)

relife-aesthetics.com
+6 more records
Core offering1 text field

Relife develops and sells a portfolio of medical aesthetic products under the Definisse™ brand, including tissue support threads, dermal fillers, chemical peels, hydration boosters, and bio-peptide collagen modulators. These products are sold to licensed healthcare professionals — dermatologists, plastic surgeons, and aesthetic practitioners — through Menarini's regional office network in Europe and Asia. The company also operates the RELIFE Academy to train practitioners on aesthetic treatment techniques.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Relife is an aesthetic medicine company offering a portfolio of aesthetic products under the Definisse™ brand family. The product line includes Definisse™ Threads (tissue support threads for lifting procedures), Definisse™ Fillers (dermal fillers for volume restoration), Definisse™ Rinnova Peel (chemical peel treatment), Definisse™ Hydrobooster (hydrating injectable), Definisse™ [KP¹]® Bio-Peptide Modulateur de Collagène (collagen-supporting bio-peptide), and the Pigment Solution™ Program (pigmentation treatment). The company also operates RELIFE Academy for training and education in aesthetic procedures. Relife is part of the Menarini Group (MENARINI FRANCE).

Product and service6 records
1Definisse™ Threads
CategoryMedical aesthetic injectables
2Definisse™ [KP¹]® Bio-Peptide Modulateur de Collagène
CategoryMedical aesthetic injectables
3Pigment Solution™ Program
CategoryMedical aesthetic treatment program
4Definisse™ Fillers
CategoryMedical aesthetic injectables
5Definisse™ Rinnova Peel
CategoryMedical aesthetic skin treatments
6Definisse™ Hydrobooster
CategoryMedical aesthetic injectables
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

Relife is a brand under the Menarini pharmaceutical group. Menarini provides corporate infrastructure, distribution networks, and manufacturing capabilities for Relife aesthetic products across international markets.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Sinclair Pharma is a close direct peer with a portfolio of aesthetic medicine products including threads, hyaluronic acid fillers, and bio-stimulators sold to aesthetic practitioners — a near-mirror of Relife's Definisse™ portfolio.

TypeEmerging player
Description

Hugel is a Korean aesthetics company with botulinum toxin (Letybo/Botulax), fillers, and bio-stimulators. It is expanding globally from an emerging-market base and competes with Relife in injectable aesthetics.

TypeBroad incumbent
Description

Allergan Aesthetics, an AbbVie division, markets leading brands including Botox, Juvederm fillers, CoolSculpting, and skin care — a dominant incumbent whose scale, clinical evidence, and marketing reach dwarf Relife's footprint.

TypeBroad incumbent
Description

Merz Aesthetics is a major global aesthetics player offering fillers (Belotero), toxins (Xeomin), and devices — a broad incumbent whose portfolio breadth and physician training compete with Relife's narrow but focused offering.

TypeBroad incumbent
Description

Galderma is one of the largest pure-play dermatology and aesthetics companies globally, with Restylane fillers, Sculptra bio-stimulator, and a broad aesthetics portfolio — a clear incumbent competing in nearly all of Relife's categories.

6Revance Therapeutics
TypeEmerging player
Description

Revance is a US-based aesthetics company with neuromodulators and the RHA dermal filler line, positioning as a science-driven emerging player in the injectable aesthetics market where Relife competes.

TypeDirect peer
Description

Teoxane is a Swiss aesthetics company specializing in hyaluronic acid dermal fillers and skin boosters, directly competing with Relife's Definisse Fillers and Hydrobooster in the injectables category.

TypeDirect peer
Description

IBSA Derma markets Profhilo and other bio-remodeling hyaluronic acid injectables, directly competing in the injectable skin quality and hydration category where Relife's Hydrobooster and KP1 bio-peptide compete.

9Croma-Pharma
TypeDirect peer
Description

Croma-Pharma manufactures and distributes a portfolio of hyaluronic acid fillers, PDO threads, and biostimulators — overlapping squarely with Relife's product mix across threads, fillers, and regenerative aesthetics.

10Aptos (threads)
TypeDirect peer
Description

Aptos is a pioneer and direct competitor in the thread lift category, marketing PDO/PLLA lifting threads — directly competing with Relife's Definisse Threads (Revitalise and 3D Lift) across aesthetic clinics.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Relife

Medical Aestheticsrelifecompany.fr

Relife is a B2B medical aesthetics brand and Menarini Group subsidiary that sells the Definisse™ portfolio of threads, fillers, peels, hydration injectables, and bio-peptide collagen modulators to licensed aesthetic practitioners across eight European and Asian markets.

What Relife does

Relife is a B2B medical aesthetics company that operates as a brand within the Menarini pharmaceutical group, with its corporate seat at Menarini France in Rungis, France. The company sells a multi-modality portfolio of medical aesthetic products under the Definisse™ brand to licensed healthcare professionals and aesthetic clinics — principally dermatologists, plastic surgeons, and aesthetic practitioners — across France, Italy, Germany, Austria, Thailand, Ireland, the United Kingdom, and Benelux. Its core product families include Definisse™ Threads (tissue support threads for lifting procedures, including Revitalise and 3D Lift variants), Definisse™ Fillers (dermal fillers for volume restoration and wrinkle correction), Definisse™ Rinnova Peel (chemical peels for skin resurfacing), Definisse™ Hydrobooster (injectable hydration), Definisse™ [KP¹]® Bio-Peptide Collagen Modulator (a bio-peptide-based collagen modulator), and the Pigment Solution™ Program for hyperpigmentation. Relife also operates the RELIFE Academy, a training platform for clinicians performing aesthetic procedures.

The company operates an enterprise field sales model, distributing products directly to healthcare professionals through the Menarini regional offices in each market. It runs eight localized websites and a dedicated academy site to support clinician education and brand engagement. Revenue is generated through one-time product sales of regulated medical devices and consumables via prescription/clinical channels; pricing is not publicly disclosed. Relife leverages the parent group's clinical, regulatory, manufacturing, and distribution infrastructure, but does not publish standalone financials, headcount, management roster, funding history, or independent revenue figures. As a brand subsidiary within a larger pharmaceutical company, Relife's strategic positioning is shaped by Menarini's broader medical aesthetics and pharmaceutical operations rather than by independent capital allocation.

Relife firmographics

Firmographics
Name
Relife
Legal name
Relife
Website
https://relifecompany.fr
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
Relife is a B2B medical aesthetics brand and Menarini Group subsidiary that sells the Definisse™ portfolio of threads, fillers, peels, hydration injectables, and bio-peptide collagen modulators to licensed aesthetic practitioners across eight European and Asian markets.
Ownership category
akta.pro rank

Relife industry classification

Industry
Product category
Medical Aesthetics
NAICS
Surgical Appliance and Supplies Manufacturing (339113)
SIC
Perfumes, Cosmetics & Other Toilet Preparations (2844), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAKACAE
Cosmetic Dermatology (Aesthetic Injectables)
SECONDARYCRABALAF
Professional Skincare & Facial Treatments
Consumer Products & Retail/Beauty & Personal Care/Professional Salon & Spa Products
SECONDARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare

Keywords

  • Medical aesthetics products
  • Dermal fillers
  • Tissue support threads
  • Chemical peels
  • Bio-peptide treatments

Where Relife is headquartered

Location

Headquarters

HQ city
Rungis
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Relife business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Marketing or Sales, Personnel, Operations, Technology or R&D

Revenue model

  1. Medical Aesthetic Products: Relife generates revenue through the sale of medical aesthetic products including tissue support threads, dermal fillers, chemical peels, and bio-peptide treatments to healthcare professionals and aesthetic clinics.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Relife product offering

Product offering

Core offering

Relife develops and sells a portfolio of medical aesthetic products under the Definisse™ brand, including tissue support threads, dermal fillers, chemical peels, hydration boosters, and bio-peptide collagen modulators. These products are sold to licensed healthcare professionals — dermatologists, plastic surgeons, and aesthetic practitioners — through Menarini's regional office network in Europe and Asia. The company also operates the RELIFE Academy to train practitioners on aesthetic treatment techniques.

Product overview

Relife is an aesthetic medicine company offering a portfolio of aesthetic products under the Definisse™ brand family. The product line includes Definisse™ Threads (tissue support threads for lifting procedures), Definisse™ Fillers (dermal fillers for volume restoration), Definisse™ Rinnova Peel (chemical peel treatment), Definisse™ Hydrobooster (hydrating injectable), Definisse™ [KP¹]® Bio-Peptide Modulateur de Collagène (collagen-supporting bio-peptide), and the Pigment Solution™ Program (pigmentation treatment). The company also operates RELIFE Academy for training and education in aesthetic procedures. Relife is part of the Menarini Group (MENARINI FRANCE).

Differentiator

Problem solved

Functional benefit

Brands

  • Definisse™ Threads: Fils de soutien tissulaire (tissue support threads)
  • Definisse™ Fillers
  • Definisse™ Rinnova Peel
  • Definisse™ Hydrobooster
  • Definisse [KP¹]® Bio-Peptide Modulateur de Collagène
  • Pigment Solutions™ Program
  • RELIFE Academy

Products and services

  • Definisse™ Threads
  • Definisse™ [KP¹]® Bio-Peptide Modulateur de Collagène
  • Pigment Solution™ Program
  • Definisse™ Fillers
  • Definisse™ Rinnova Peel
  • Definisse™ Hydrobooster

Companies that use Relife

Customer profile

Segments1 record

Ideal customer profiles1 record

Relife technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Relife partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Menarini GroupcoreOthersRelife is a brand under the Menarini pharmaceutical group. Menarini provides corporate infrastructure, distribution networks, and manufacturing capabilities for Relife aesthetic products across international markets.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Relife competitors and assessment

Company assessment

Direct peers

  • Sinclair Pharma: Sinclair Pharma is a close direct peer with a portfolio of aesthetic medicine products including threads, hyaluronic acid fillers, and bio-stimulators sold to aesthetic practitioners — a near-mirror of Relife's Definisse™ portfolio.
  • Teoxane: Teoxane is a Swiss aesthetics company specializing in hyaluronic acid dermal fillers and skin boosters, directly competing with Relife's Definisse Fillers and Hydrobooster in the injectables category.
  • IBSA Derma: IBSA Derma markets Profhilo and other bio-remodeling hyaluronic acid injectables, directly competing in the injectable skin quality and hydration category where Relife's Hydrobooster and KP1 bio-peptide compete.
  • Croma-Pharma: Croma-Pharma manufactures and distributes a portfolio of hyaluronic acid fillers, PDO threads, and biostimulators — overlapping squarely with Relife's product mix across threads, fillers, and regenerative aesthetics.
  • Aptos (threads): Aptos is a pioneer and direct competitor in the thread lift category, marketing PDO/PLLA lifting threads — directly competing with Relife's Definisse Threads (Revitalise and 3D Lift) across aesthetic clinics.

Emerging players

  • Hugel: Hugel is a Korean aesthetics company with botulinum toxin (Letybo/Botulax), fillers, and bio-stimulators. It is expanding globally from an emerging-market base and competes with Relife in injectable aesthetics.
  • Revance Therapeutics: Revance is a US-based aesthetics company with neuromodulators and the RHA dermal filler line, positioning as a science-driven emerging player in the injectable aesthetics market where Relife competes.

Broad incumbents

  • Allergan Aesthetics (AbbVie): Allergan Aesthetics, an AbbVie division, markets leading brands including Botox, Juvederm fillers, CoolSculpting, and skin care — a dominant incumbent whose scale, clinical evidence, and marketing reach dwarf Relife's footprint.
  • Merz Aesthetics: Merz Aesthetics is a major global aesthetics player offering fillers (Belotero), toxins (Xeomin), and devices — a broad incumbent whose portfolio breadth and physician training compete with Relife's narrow but focused offering.
  • Galderma: Galderma is one of the largest pure-play dermatology and aesthetics companies globally, with Restylane fillers, Sculptra bio-stimulator, and a broad aesthetics portfolio — a clear incumbent competing in nearly all of Relife's categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Relife social profiles

Digital presence

Relife financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Relife leadership team

Management profile

Number of profiles

Relife funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Relife M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Relife

What does Relife do?

Relife develops and sells a portfolio of medical aesthetic products under the Definisse™ brand, including tissue support threads, dermal fillers, chemical peels, hydration boosters, and bio-peptide collagen modulators. These products are sold to licensed healthcare professionals — dermatologists, plastic surgeons, and aesthetic practitioners — through Menarini's regional office network in Europe and Asia. The company also operates the RELIFE Academy to train practitioners on aesthetic treatment techniques.

Is Relife a public or private company?

Relife is a private company. It is classified as corporate owned and is currently operating.

When was Relife founded?

Relife was founded in 2016. It employs 1 to 10 people.

Where is Relife based?

Relife is headquartered in Rungis, France, in the Europe region.

How does Relife make money?

One revenue line is on record: medical Aesthetic Products.

Who are Relife's main competitors?

Direct peers on record are Sinclair Pharma, Teoxane, IBSA Derma, Croma-Pharma and Aptos (threads). Emerging players are Hugel and Revance Therapeutics. Broad incumbents are Allergan Aesthetics (AbbVie), Merz Aesthetics and Galderma.

Does Relife have an API?

No public API is recorded for Relife.

What industry is Relife in?

Relife's product category is Medical Aesthetics. Its primary akta.pro industry code is HLAKACAE, Cosmetic Dermatology (Aesthetic Injectables), with a secondary code of CRABALAF, Professional Skincare & Facial Treatments. Its NAICS code is 339113 and its SIC code is 2844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Medical IndependentMelanin transfer and processing in focusProfessor Duarte C Barral from NOVA University of Lisbon presented research on the molecular mechanisms of melanin transfer and processing at a seminar hosted by the Charles Institute in Ireland. The study, sponsored by RELIFE (part of the A.Menarini group), details specific protein regulators like Rab11b and Rab7 that control how melanin is secreted by melanocytes and processed by keratinocytes to determine skin pigmentation.PR NewswireLipidor Announces Enrolment of First Patients in a Phase III Study on AKP02 for Treatment of PsoriasisLipidor AB has enrolled the first patients in a Phase III clinical study for AKP02, a spray-based treatment combining calcipotriol and betamethasone for mild to moderate psoriasis, with 294 patients to be treated at 13 clinics in India. The observer-blind, placebo-controlled study is being conducted by Cadila Pharmaceuticals, with results expected in Q2 2022, and will compare AKP02 against Enstilar foam as a benchmark. Lipidor's commercial partner RELIFE (part of Menarini Group) and industrial owner Aurena Laboratories are collaborating to bring both AKP01 and AKP02 to market.DentistryCreating the beauty of the moment with RelifeA webinar on Relife's Definisse products is scheduled for 19:00 on 29 June 2021, featuring cosmetic doctors and experts. Speakers include Dr Vincent Wong, Dr Martyn King, Jackie Knight, Dalvi Humzah, and Dr Simon Zokaie, who will share case studies. Free registration is available via dentistry.co.uk/webinar.